Tadalafil Ozon: Compound Profile
Tadalafil Ozon is a phosphodiesterase-5 (PDE5) inhibitor compound extensively investigated in cardiovascular and smooth muscle research applications. This molecular entity demonstrates selective inhibition of the PDE5 enzyme, which plays a crucial role in cyclic guanosine monophosphate (cGMP) degradation pathways. Research laboratories examining vascular biology and nitric oxide signalling mechanisms frequently incorporate this compound into their experimental protocols. The molecular structure of tadalafil contains a distinctive benzoisothiazole core, distinguishing it from other PDE5 inhibitors in comparative studies. Investigators at Stroid UK Shop have access to laboratory-grade formulations specifically prepared for in-vitro research applications.
Research Applications and Mechanisms
Laboratory investigations utilise tadalafil to examine PDE5 enzyme kinetics and its role in smooth muscle relaxation pathways. Research models demonstrate that this compound exhibits reversible competitive inhibition of PDE5 with high selectivity compared to other phosphodiesterase families. Cell culture studies investigate the downstream effects on intracellular cGMP concentrations and subsequent protein kinase G activation cascades. Cardiovascular research laboratories explore the compound’s effects on vascular endothelial function and nitric oxide-dependent vasodilation mechanisms. Comparative studies with other PDE5 inhibitors reveal unique pharmacokinetic properties including extended half-life characteristics. Research institutions also investigate potential applications in pulmonary hypertension models and cardiac remodelling studies. Advanced laboratories examine the molecular interactions between tadalafil and various PDE isozymes to understand selectivity profiles. Some research groups explore combinations with selective androgen receptor modulators or peptide research compounds in multi-pathway investigations.
Research Specifications
| Parameter | Specification |
|---|---|
| Chemical Formula | C₂₂H₁₉N₃O₄ |
| Molecular Weight | 389.40 g/mol |
| CAS Number | 171596-29-5 |
| Storage Temperature | Room temperature, dry conditions |
| Solubility | Research-grade solvents recommended |
| Research Purity | Verify with supplier documentation |
Research Safety and Compliance
This compound is manufactured and supplied exclusively for laboratory research purposes under appropriate institutional oversight. Research facilities must maintain proper safety protocols including adequate ventilation, personal protective equipment, and waste disposal procedures according to institutional guidelines. Storage requires controlled laboratory conditions away from direct light and moisture exposure. All research applications must comply with institutional review board requirements and applicable research regulations. This product is not intended for human consumption, therapeutic applications, or any use outside accredited research facilities with appropriate safety infrastructure and qualified personnel supervision.
